Monocl
A platform for life science companies to cooperate on drug research, sales, marketing and recruitment.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
N/A | Acquisition | ||
| Total Funding | 000k | ||
| EUR | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 138 % | 106 % | 59 % | 87 % | 101 % | 9 % | (7 %) |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (41 %) | (68 %) | (113 %) | (23 %) | - | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (49 %) | (72 %) | (132 %) | (28 %) | (17 %) | (1 %) | 16 % |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Monocl was established in 2010 by co-founders Björn Carlsson and Daniel Caneva in Gothenburg, Sweden. Carlsson, who serves as the CEO, brought his experience from the pharmaceutical industry, while Caneva contributed his background in software engineering, creating a foundation aimed at improving how life science professionals connect and collaborate. The company carved out a niche for itself by developing a sophisticated platform to map and understand the landscape of experts in the life sciences and healthcare sectors.
The core of Monocl's business is its cloud-based stakeholder engagement platform, which provides deep insights into millions of experts worldwide, including scientific researchers, clinical investigators, and other key opinion leaders (KOLs). This platform is designed to help life science companies, such as pharmaceutical and biotech firms, identify and engage with the most relevant experts for their specific needs, whether for clinical trials, medical affairs, or commercial activities. The service operates on a software-as-a-service (SaaS) model, generating revenue through subscriptions to its platform. Its main product, Monocl ExpertInsight, uses machine learning to analyze vast amounts of data, offering detailed profiles and network visualisations of these experts.
A significant milestone in the company's history occurred in October 2020, when it was acquired by Definitive Healthcare for approximately $90 million. This acquisition integrated Monocl's expert identification capabilities into Definitive Healthcare's broader suite of data and analytics solutions for the healthcare ecosystem, creating a more comprehensive offering for clients. The combination allows users to not only identify key experts but also to understand their professional networks, publication history, and clinical trial involvement in great detail.
Keywords: expert intelligence, key opinion leaders, life sciences, pharmaceuticals, biotech, medical affairs, stakeholder engagement, SaaS, data analytics, healthcare intelligence